Checkout
Please register your details and proceed to checkout.
Uterine Fibroids Drug Pipeline Analysis 2024: By Clinical Trial Phase: Late-Stage Products (Phase III and Phase IV), Mid-Stage Products (Phase II), Early-Stage Products (Phase I), Preclinical and Discovery Stage Products; By Drug Class: Gonadotropin-Releasing Hormone (GnRH) Agonists, GnRH Antagonists, Selective Progesterone Receptor Modulators (SPRMs), Progestins; By Product Type; By Treatment Type; Key Players
Single User License
$ 2499.00
Total Price: $ 2499.00
We use cookies, just to track visits to our website, we store no personal details. Privacy PolicyX
Reports
Press Release
Blogs
Price Forecast